Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12084447 SHP2 phosphatase inhibitors and methods of use thereof

Patent 12084447 was granted and assigned to Relay Therapeutics on September, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Relay Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

120844470

Patent Inventor Names

Eric Therrien0

Alexander M. Taylor0

André Lescarbeau0

Mark Andrew Murcko0

Fabrizio Giordanetto0

Hakan Gunaydin0

Kelley C. Shortsleeves0

W. Patrick Walters0

...

Date of Patent

September 10, 2024

Patent Application Number

169505760

Date Filed

November 17, 2020

Patent Citations

‌

US Patent 10988466 Heterocyclic derivatives useful as SHP2 inhibitors

‌

US Patent 10280171 Heterocyclic inhibitors of PTPN11

‌

US Patent 10934302 SHP2 phosphatase inhibitors and methods of use thereof

‌

US Patent 11529347 SHP2 phosphatase inhibitors and methods of use thereof

Patent Primary Examiner

‌

Jeffrey S Lundgren

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12084447 SHP2 phosphatase inhibitors and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API